Read on Twitter
NOVACYT
Very interesting response by testing stocks over the past few days.
We've all been watching carefully as vaccine news rolls in and UK Gov signs deals
When #NCYT director is buying shares - not selling them, you know they're serious about Mid Cap.
#ALNOV #NVYTF #AVCT
Very interesting response by testing stocks over the past few days.
We've all been watching carefully as vaccine news rolls in and UK Gov signs deals
When #NCYT director is buying shares - not selling them, you know they're serious about Mid Cap.
#ALNOV #NVYTF #AVCT
The last time directors bought in was during a period of volatility around £3.
The share price later rallied on to £12. Snape has averaged up today, paying over 100% more since then.
It is too easy to put out a few tweets or an RNS statement telling your shareholders it's fine.
The share price later rallied on to £12. Snape has averaged up today, paying over 100% more since then.
It is too easy to put out a few tweets or an RNS statement telling your shareholders it's fine.
But it's not fine.
Shareholders have a lot of money in these stocks - they're investing in companies they have been led to believe will deliver results.
Companies must put their money where their mouth is.
Deals must be signed. Products released while the market is there.
Shareholders have a lot of money in these stocks - they're investing in companies they have been led to believe will deliver results.
Companies must put their money where their mouth is.
Deals must be signed. Products released while the market is there.
Novacyt has responded by putting their money where their mouth is, and will continue to do so.
You will only see growth from this company all the way to mid cap. They will have revenues and profits beyond anything else on AIM for years.
You will only see growth from this company all the way to mid cap. They will have revenues and profits beyond anything else on AIM for years.
Non-Covid plan is underway behind the scenes and strategic and non-covid acquisitions in Transplant Diagnostics and Infectious Diseases are being lined up for H1 2021.
Those Q16s and Q32s are not temporary.
They are not a disposable product.
Those Q16s and Q32s are not temporary.
They are not a disposable product.
They are rolling out across the UK and will later be used not just for multiplex (which the NHS and other global organisations will be using beyond the pandemic), but for non-covid applications too.
The future is empowering hospitals.
The future is empowering hospitals.
A few Q32s in a hospital ward will not only test for infectious diseases rapidly - it can be used for oncology and transplant surgery testing.
No more sending samples from hospitals and clinics to labs.
Hospitals and clinics will now BECOME labs, rapid easy to use ones.
No more sending samples from hospitals and clinics to labs.
Hospitals and clinics will now BECOME labs, rapid easy to use ones.
And Novacyt's world leading brand - NHS approved and first to market for innovation will now help place these Q-series units everywhere, in over 100 countries:
See the scale: https://www.dropbox.com/s/zo1e7lwtv5r13c4/Primerdesign%20-%20genesig%20List%20distr%20%26%20countries%20ver%2008%20Nov%202020.xlsx?dl=0
See the scale: https://www.dropbox.com/s/zo1e7lwtv5r13c4/Primerdesign%20-%20genesig%20List%20distr%20%26%20countries%20ver%2008%20Nov%202020.xlsx?dl=0
The scale of what's happening here is beyond covid, beyond the UK, it's a masterpiece by a brilliant board who are being handed a massive cash and well deserved Warchest from getting stuck in and saving lives.
They deserve all of it.
They deserve all of it.
The volatility in vaccines was always coming, some of us tgently put the message out recently, but we didn't bail.
Why? Because it's a temporary blip on the way to mid cap.
Been here for a good while and will be here for a good while longer.
Why? Because it's a temporary blip on the way to mid cap.
Been here for a good while and will be here for a good while longer.
Rare I'd post a buy on Twitter, not my thing, but if Ed is showing his hand and buying some cheap shares, then I can reveal mine too.
A lot of us topped up and I know none that sold a single share. +860 - that's what CINE rallies are for. For buying more Novacyt.
A lot of us topped up and I know none that sold a single share. +860 - that's what CINE rallies are for. For buying more Novacyt.
Onwards and upwards.
We are not a covid stock.
We are a covid Warchest stock and now we're going on an M&A spending spree.
See our top two 3.5 Billion AIM Mid Cap biotech competitors. They make nothing compared to Novacyt.
https://novacytinsider.com/abcam-hutch/
We are not a covid stock.
We are a covid Warchest stock and now we're going on an M&A spending spree.
See our top two 3.5 Billion AIM Mid Cap biotech competitors. They make nothing compared to Novacyt.
https://novacytinsider.com/abcam-hutch/
Our Mcap unlocks as the non-covid news emerges.
This is a 2021 high growth stock.
Suck up the volatility as we shed the covid image and separate ourselves from the rest.
Like dot com - there were winners and losers.
Novacyt is the Amazon of Covid
This is a 2021 high growth stock.
Suck up the volatility as we shed the covid image and separate ourselves from the rest.
Like dot com - there were winners and losers.
Novacyt is the Amazon of Covid
And like Amazon, we're rapidly innovating and our Next Gen tech is coming from @MicrogenBioProd and @PrimerdesignLtd
Been one hell of a year, but 2021 is when a star is born.
Novacyt is here to stay.
Cheers Ed & the team, appreciate the message today
Been one hell of a year, but 2021 is when a star is born.
Novacyt is here to stay.
Cheers Ed & the team, appreciate the message today
